Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics & Global Health 2018

Claudio Parolo's Biography



Claudio Parolo, Research Fellow, University of California-Santa Barbara

Claudio Parolo received his M.S. degree in industrial biotechnology from University of Padova and his PhD in biotechnology from Autonomous University of Barcelona. His graduate and postgraduate research focused on the development of electrochemical and optical paper-based diagnostic devices (Harvard University and University College London), including a lateral flow immunoassay used to diagnose Ebola in rural Uganda. Since 2016, he is a postdoctoral fellow at the University of California Santa Barbara (Plaxco group) working on the development of novel serological techniques.

Claudio Parolo Image

From Epitopes to Antigens: Expanding the Capabilities of E-DNA Switches in Diagnostics

Wednesday, 3 October 2018 at 15:00

Add to Calendar ▼2018-10-03 15:00:002018-10-03 16:00:00Europe/LondonFrom Epitopes to Antigens: Expanding the Capabilities of E-DNA Switches in DiagnosticsPoint-of-Care Diagnostics and Global Health 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Being antibodies one of the widest and most versatile class of diagnostic biomarkers, there is a surprising lack of technologies by which we can measure the levels of multiple diagnostic antibodies at the point of care during the few minute timeframe of a typical patient/provider interaction. In response, we developed just such a technology (called E-DNA switches), which is reagentless, single-step, selective enough to deploy in high-concentration blood serum, miniaturizable and fast (the equilibration time constant of antibodies is a few minutes). In this presentation, I will show how we used the E-DNA switches technology for the detection of multiple HIV- and Syphilis-specific antibodies in real patient samples. I will also compare our results with those of the enzyme-linked immunosorbent assay (ELISA), proving that we can obtain high quality diagnosis using a point-of-care platform.


Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health 2018Point-of-Care Diagnostics and Global Health 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com